Evidence map›Paper›PMID 37694108›Full record

ArticleFrontiers in neuroscience2023

Sensitivity analysis of point neuron model simulations implemented on neuromorphic hardware.

Srijanie Dey, Alexander G Dimitrov

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Neuromorphic Devices and Computing for Sensing, Memory, and Control.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Srijanie DeyDepartment of Mathematics, Washington State University, Vancouver, WA, United States.
Alexander G DimitrovDepartment of Mathematics, Washington State University, Vancouver, WA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the ongoing growth in the field of neuro-inspired computing, newly arriving computational architectures demand extensive validation and testing against existing benchmarks to establish their competence and value. In our work, we break down the validation step into two parts-(1) establishing a methodological and numerical groundwork to establish a comparison between neuromorphic and conventional platforms and, (2) performing a sensitivity analysis on the obtained model regime to assess its robustness. We study the neuronal dynamics based on the Leaky Integrate and Fire (LIF) model, which is built upon data from the mouse visual cortex spanning a set of anatomical and physiological constraints. Intel Corp.'s first neuromorphic chip "Loihi" serves as our neuromorphic platform and results on it are validated against the classical simulations. After setting up a model that allows a seamless mapping between the Loihi and the classical simulations, we find that Loihi replicates classical simulations very efficiently with high precision. This model is then subjected to the second phase of validation, through sensitivity analysis, by assessing the impact on the cost function as values of the significant model parameters are varied. The work is done in two steps-(1) assessing the impact while changing one parameter at a time, (2) assessing the impact while changing two parameters at a time. We observe that the model is quite robust for majority of the parameters with slight change in the cost function. We also identify a subset of the model parameters changes which make the model more sensitive and thus, need to be defined more precisely.

Indexed as

LIF modelsneural simulationsneuromorphic computingsensitivity analysisvalidation

Identifiers

PMID37694108
PMCPMC10484528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.